2 results
Approved WMORecruiting
To assess the efficacy and safety of LCI699 in CD patients
Approved WMORecruiting
Comparing the effectiveness and cost-effectiveness of narrowband ultraviolet B with optimal topical therapy (NB-UVB+OTT) versus OTT at 3 months in adult patients with atopic eczema (AE).